Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1683

1.

Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro.

Aslan O, Cremona M, Morgan C, Cheung LW, Mills GB, Hennessy BT.

BMC Cancer. 2018 Feb 9;18(1):168. doi: 10.1186/s12885-018-4035-0.

2.

PRECISION ONCOLOGY DECISION SUPPORT: CURRENT APPROACHES AND STRATEGIES FOR THE FUTURE.

Kurnit KC, Ileana Dumbrava EE, Litzenburger BC, Khotskaya YB, Johnson A, Yap TA, Rodon J, Zeng J, Shufean MA, Bailey A, Sánchez N, Holla VR, Mendelsohn J, Shaw KRM, Bernstam EV, Mills GB, Meric-Bernstam F.

Clin Cancer Res. 2018 Feb 2. pii: clincanres.2494.2017. doi: 10.1158/1078-0432.CCR-17-2494. [Epub ahead of print]

PMID:
29420224
3.

Evaluation of Diffusive Gradients in Thin-Films for Prediction of Copper Bioaccumulation by Yellow Lampmussel (Lampsilis cariosa) and Fathead Minnow (Pimephales promelas).

Philipps RR, Xu X, Mills GL, Bringolf RB.

Environ Toxicol Chem. 2018 Feb 5. doi: 10.1002/etc.4108. [Epub ahead of print]

PMID:
29405356
4.

Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin.

Jeong BY, Cho KH, Jeong KJ, Park YY, Kim JM, Rha SY, Park CG, Mills GB, Cheong JH, Lee HY.

Exp Mol Med. 2018 Jan 26;50(1):e435. doi: 10.1038/emm.2017.248.

5.

Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.

Robertson AG, Shih J, Yau C, Gibb EA, Oba J, Mungall KL, Hess JM, Uzunangelov V, Walter V, Danilova L, Lichtenberg TM, Kucherlapati M, Kimes PK, Tang M, Penson A, Babur O, Akbani R, Bristow CA, Hoadley KA, Iype L, Chang MT; TCGA Research Network, Cherniack AD, Benz C, Mills GB, Verhaak RGW, Griewank KG, Felau I, Zenklusen JC, Gershenwald JE, Schoenfield L, Lazar AJ, Abdel-Rahman MH, Roman-Roman S, Stern MH, Cebulla CM, Williams MD, Jager MJ, Coupland SE, Esmaeli B, Kandoth C, Woodman SE.

Cancer Cell. 2018 Jan 8;33(1):151. doi: 10.1016/j.ccell.2017.12.013. No abstract available.

6.

Respiratory complications of anaesthesia.

Mills GH.

Anaesthesia. 2018 Jan;73 Suppl 1:25-33. doi: 10.1111/anae.14137. Review.

PMID:
29313906
7.

Calibration and field evaluation of the Chemcatcher® passive sampler for monitoring metaldehyde in surface water.

Castle GD, Mills GA, Bakir A, Gravell A, Schumacher M, Townsend I, Jones L, Greenwood R, Knott S, Fones GR.

Talanta. 2018 Mar 1;179:57-63. doi: 10.1016/j.talanta.2017.10.053. Epub 2017 Nov 22.

8.

Longevity after radiotherapy of stage III lung cancer: superior vena cava obstruction is associated with early mortality.

Ampil FL, Caldito G, Devarakonda S, Vora M, Mills G, Milligan S.

Ann Palliat Med. 2017 Nov 24. pii: apm.2017.10.02. doi: 10.21037/apm.2017.10.02. [Epub ahead of print]

9.

Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients.

Mauland KK, Ju Z, Tangen IL, Berg A, Kalland KH, Øyan AM, Bjørge L, Westin SN, Krakstad C, Trovik J, Mills GB, Hoivik EA, Johanna Werner HM.

Oncotarget. 2017 Oct 31;8(63):106989-107001. doi: 10.18632/oncotarget.22203. eCollection 2017 Dec 5.

10.

Characteristics of percutaneous core biopsies adequate for next generation genomic sequencing.

Sabir SH, Krishnamurthy S, Gupta S, Mills GB, Wei W, Cortes AC, Mills Shaw KR, Luthra R, Wallace MJ.

PLoS One. 2017 Dec 27;12(12):e0189651. doi: 10.1371/journal.pone.0189651. eCollection 2017.

11.

Survival of Cancer Stem-Like Cells Under Metabolic Stress via CaMK2α-mediated Upregulation of Sarco/Endoplasmic Reticulum Calcium ATPase Expression.

Park KC, Kim SW, Jeon JY, Jo AR, Choi HJ, Kim J, Lee HG, Kim Y, Mills GB, Noh SH, Lee MG, Park ES, Cheong JH.

Clin Cancer Res. 2017 Dec 26. doi: 10.1158/1078-0432.CCR-17-2219. [Epub ahead of print]

PMID:
29279319
12.

Ex Vivo Confocal Fluorescence Microscopy for Rapid Evaluation of Tissues in Surgical Pathology Practice.

Krishnamurthy S, Cortes A, Lopez M, Wallace M, Sabir S, Shaw K, Mills G.

Arch Pathol Lab Med. 2017 Dec 21. doi: 10.5858/arpa.2017-0164-OA. [Epub ahead of print]

PMID:
29266968
13.

The distribution and numbers of cheetah (Acinonyx jubatus) in southern Africa.

Weise FJ, Vijay V, Jacobson AP, Schoonover RF, Groom RJ, Horgan J, Keeping D, Klein R, Marnewick K, Maude G, Melzheimer J, Mills G, van der Merwe V, van der Meer E, van Vuuren RJ, Wachter B, Pimm SL.

PeerJ. 2017 Dec 11;5:e4096. doi: 10.7717/peerj.4096. eCollection 2017.

14.

A feasibility study of neoadjuvant talazoparib for operable breast cancer patients with a germline BRCA mutation demonstrates marked activity.

Litton JK, Scoggins M, Ramirez DL, Murthy RK, Whitman GJ, Hess KR, Adrada BE, Moulder SL, Barcenas CH, Valero V, Gomez JS, Mittendorf EA, Thompson A, Helgason T, Mills GB, Piwnica-Worms H, Arun BK.

NPJ Breast Cancer. 2017 Dec 6;3:49. doi: 10.1038/s41523-017-0052-4. eCollection 2017.

15.

Excellent response to chemotherapy post immunotherapy.

Dwary AD, Master S, Patel A, Cole C, Mansour R, Mills G, Koshy N, Peddi P, Burton G, Hammoud D, Beedupalli K.

Oncotarget. 2017 Aug 8;8(53):91795-91802. doi: 10.18632/oncotarget.20030. eCollection 2017 Oct 31.

16.

The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations.

Keenan AB, Jenkins SL, Jagodnik KM, Koplev S, He E, Torre D, Wang Z, Dohlman AB, Silverstein MC, Lachmann A, Kuleshov MV, Ma'ayan A, Stathias V, Terryn R, Cooper D, Forlin M, Koleti A, Vidovic D, Chung C, Schürer SC, Vasiliauskas J, Pilarczyk M, Shamsaei B, Fazel M, Ren Y, Niu W, Clark NA, White S, Mahi N, Zhang L, Kouril M, Reichard JF, Sivaganesan S, Medvedovic M, Meller J, Koch RJ, Birtwistle MR, Iyengar R, Sobie EA, Azeloglu EU, Kaye J, Osterloh J, Haston K, Kalra J, Finkbiener S, Li J, Milani P, Adam M, Escalante-Chong R, Sachs K, Lenail A, Ramamoorthy D, Fraenkel E, Daigle G, Hussain U, Coye A, Rothstein J, Sareen D, Ornelas L, Banuelos M, Mandefro B, Ho R, Svendsen CN, Lim RG, Stocksdale J, Casale MS, Thompson TG, Wu J, Thompson LM, Dardov V, Venkatraman V, Matlock A, Van Eyk JE, Jaffe JD, Papanastasiou M, Subramanian A, Golub TR, Erickson SD, Fallahi-Sichani M, Hafner M, Gray NS, Lin JR, Mills CE, Muhlich JL, Niepel M, Shamu CE, Williams EH, Wrobel D, Sorger PK, Heiser LM, Gray JW, Korkola JE, Mills GB, LaBarge M, Feiler HS, Dane MA, Bucher E, Nederlof M, Sudar D, Gross S, Kilburn DF, Smith R, Devlin K, Margolis R, Derr L, Lee A, Pillai A.

Cell Syst. 2018 Jan 24;6(1):13-24. doi: 10.1016/j.cels.2017.11.001. Epub 2017 Nov 29. Review.

PMID:
29199020
17.

Surviving Ovarian Cancer: An Affair between Defective DNA Repair and RB1.

Peng G, Mills GB.

Clin Cancer Res. 2018 Feb 1;24(3):508-510. doi: 10.1158/1078-0432.CCR-17-3022. Epub 2017 Nov 30.

PMID:
29191971
18.

Physician interpretation of genomic test results and treatment selection.

Brusco LL, Wathoo C, Mills Shaw KR, Holla VR, Bailey AM, Johnson AM, Khotskaya YB, Litzenburger BC, Sanchez NS, Zeng J, Bernstam EV, Eng C, Kee BK, Amaria RN, Routbort MJ, Mills GB, Mendelsohn J, Meric-Bernstam F.

Cancer. 2018 Mar 1;124(5):966-972. doi: 10.1002/cncr.31112. Epub 2017 Nov 22.

PMID:
29165790
19.

Reflections on HTM, Compliance, and Patient Safety.

Mills G.

Biomed Instrum Technol. 2017 Nov./Dec.;51(6):456. doi: 10.2345/0899-8205-51.6.456. No abstract available.

PMID:
29161131
20.

A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma.

Krepler C, Sproesser K, Brafford P, Beqiri M, Garman B, Xiao M, Shannan B, Watters A, Perego M, Zhang G, Vultur A, Yin X, Liu Q, Anastopoulos IN, Wubbenhorst B, Wilson MA, Xu W, Karakousis G, Feldman M, Xu X, Amaravadi R, Gangadhar TC, Elder DE, Haydu LE, Wargo JA, Davies MA, Lu Y, Mills GB, Frederick DT, Barzily-Rokni M, Flaherty KT, Hoon DS, Guarino M, Bennett JJ, Ryan RW, Petrelli NJ, Shields CL, Terai M, Sato T, Aplin AE, Roesch A, Darr D, Angus S, Kumar R, Halilovic E, Caponigro G, Jeay S, Wuerthner J, Walter A, Ocker M, Boxer MB, Schuchter L, Nathanson KL, Herlyn M.

Cell Rep. 2017 Nov 14;21(7):1953-1967. doi: 10.1016/j.celrep.2017.10.021.

21.

Development and evaluation of a new diffusive gradients in thin-films technique for measuring organotin compounds in coastal sediment pore water.

Cole RF, Mills GA, Hale MS, Parker R, Bolam T, Teasdale PR, Bennett WW, Fones GR.

Talanta. 2018 Feb 1;178:670-678. doi: 10.1016/j.talanta.2017.09.081. Epub 2017 Oct 7.

22.

Comprehensive Characterization of Alternative Polyadenylation in Human Cancer.

Xiang Y, Ye Y, Lou Y, Yang Y, Cai C, Zhang Z, Mills T, Chen NY, Kim Y, Muge Ozguc F, Diao L, Karmouty-Quintana H, Xia Y, Kellems RE, Chen Z, Blackburn MR, Yoo SH, Shyu AB, Mills GB, Han L.

J Natl Cancer Inst. 2017 Nov 2. doi: 10.1093/jnci/djx223. [Epub ahead of print]

PMID:
29106591
23.

A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors.

Evans KW, Yuca E, Akcakanat A, Scott SM, Arango NP, Zheng X, Chen K, Tapia C, Tarco E, Eterovic AK, Black DM, Litton JK, Yap TA, Tripathy D, Mills GB, Meric-Bernstam F.

Clin Cancer Res. 2017 Nov 1;23(21):6468-6477. doi: 10.1158/1078-0432.CCR-17-0615.

PMID:
29093017
24.

"Personalized Cancer Therapy": A Publicly Available Precision Oncology Resource.

Kurnit KC, Bailey AM, Zeng J, Johnson AM, Shufean MA, Brusco L, Litzenburger BC, Sánchez NS, Khotskaya YB, Holla V, Simpson A, Mills GB, Mendelsohn J, Bernstam E, Shaw K, Meric-Bernstam F.

Cancer Res. 2017 Nov 1;77(21):e123-e126. doi: 10.1158/0008-5472.CAN-17-0341.

PMID:
29092956
25.

Explore, Visualize, and Analyze Functional Cancer Proteomic Data Using the Cancer Proteome Atlas.

Li J, Akbani R, Zhao W, Lu Y, Weinstein JN, Mills GB, Liang H.

Cancer Res. 2017 Nov 1;77(21):e51-e54. doi: 10.1158/0008-5472.CAN-17-0369.

PMID:
29092939
26.

The Impact and Functional Outcomes of Achilles Tendon Pathology in National Basketball Association Players.

Amin NH, McCullough KC, Mills GL, Jones MH, Cerynik DL, Rosneck J, Parker RD.

Clin Res Foot Ankle. 2016 Sep;4(3). pii: 205. doi: 10.4172/2329-910X.1000205. Epub 2016 Sep 23.

27.

Effectiveness of real-time polymerase chain reaction assay for the detection of Mycobacterium tuberculosis in pathological samples: a systematic review and meta-analysis.

Babafemi EO, Cherian BP, Banting L, Mills GA, Ngianga K 2nd.

Syst Rev. 2017 Oct 25;6(1):215. doi: 10.1186/s13643-017-0608-2.

28.

Precision oncology: neither a silver bullet nor a dream.

Sánchez NS, Mills GB, Mills Shaw KR.

Pharmacogenomics. 2017 Nov;18(16):1525-1539. doi: 10.2217/pgs-2017-0094. Epub 2017 Oct 24.

PMID:
29061079
29.

The Association between Mortality and Distance to Treatment Facility in Patients with Muscle Invasive Bladder Cancer.

Ryan S, Serrell EC, Karabon P, Mills G, Hansen M, Hayn M, Menon M, Trinh QD, Abdollah F, Sammon JD.

J Urol. 2018 Feb;199(2):424-429. doi: 10.1016/j.juro.2017.10.011. Epub 2017 Oct 10.

PMID:
29030318
30.

Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.

Korkola JE, Collisson EA, Heiser LM, Oates C, Bayani N, Itani S, Esch A, Thompson W, Griffith OL, Wang NJ, Kuo WL, Cooper B, Billig J, Ziyad S, Hung JL, Jakkula L, Feiler H, Lu Y, Mills GB, Spellman PT, Tomlin C, Mukherjee S, Gray JW.

PLoS One. 2017 Oct 11;12(10):e0186551. doi: 10.1371/journal.pone.0186551. eCollection 2017.

31.

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.

Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, Hinoue T, Laird PW, Hoadley KA, Akbani R, Castro MAA, Gibb EA, Kanchi RS, Gordenin DA, Shukla SA, Sanchez-Vega F, Hansel DE, Czerniak BA, Reuter VE, Su X, de Sa Carvalho B, Chagas VS, Mungall KL, Sadeghi S, Pedamallu CS, Lu Y, Klimczak LJ, Zhang J, Choo C, Ojesina AI, Bullman S, Leraas KM, Lichtenberg TM, Wu CJ, Schultz N, Getz G, Meyerson M, Mills GB, McConkey DJ; TCGA Research Network, Weinstein JN, Kwiatkowski DJ, Lerner SP.

Cell. 2017 Oct 19;171(3):540-556.e25. doi: 10.1016/j.cell.2017.09.007. Epub 2017 Oct 5.

PMID:
28988769
32.

The effect of sepsis and septic shock on the viscoelastic properties of clot quality and mass using rotational thromboelastometry: A prospective observational study.

Davies GR, Lawrence M, Pillai S, Mills GM, Aubrey R, Thomas D, Williams R, Morris K, Evans PA.

J Crit Care. 2017 Oct 2;44:7-11. doi: 10.1016/j.jcrc.2017.09.183. [Epub ahead of print]

PMID:
28988002
33.

Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.

Han G, Zhao W, Song X, Kwok-Shing Ng P, Karam JA, Jonasch E, Mills GB, Zhao Z, Ding Z, Jia P.

BMC Genomics. 2017 Oct 3;18(Suppl 6):678. doi: 10.1186/s12864-017-4026-6.

34.

Exploring genome-wide DNA methylation patterns in Aicardi syndrome.

Piras IS, Mills G, Llaci L, Naymik M, Ramsey K, Belnap N, Balak CD, Jepsen WM, Szelinger S, Siniard AL, Lewis CR, LaFleur M, Richholt RF, De Both MD, Avela K, Rangasamy S, Craig DW, Narayanan V, Järvelä I, Huentelman MJ, Schrauwen I.

Epigenomics. 2017 Nov;9(11):1373-1386. doi: 10.2217/epi-2017-0060. Epub 2017 Oct 2.

PMID:
28967789
35.

PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas.

Lu H, Liu S, Zhang G, Bin Wu, Zhu Y, Frederick DT, Hu Y, Zhong W, Randell S, Sadek N, Zhang W, Chen G, Cheng C, Zeng J, Wu LW, Zhang J, Liu X, Xu W, Krepler C, Sproesser K, Xiao M, Miao B, Liu J, Song CD, Liu JY, Karakousis GC, Schuchter LM, Lu Y, Mills G, Cong Y, Chernoff J, Guo J, Boland GM, Sullivan RJ, Wei Z, Field J, Amaravadi RK, Flaherty KT, Herlyn M, Xu X, Guo W.

Nature. 2017 Oct 5;550(7674):133-136. doi: 10.1038/nature24040. Epub 2017 Sep 27.

PMID:
28953887
36.

Erratum: Niche-localized tumor cells are protected from HER2-targeted therapy via upregulation of an anti-apoptotic program in vivo.

Zoeller JJ, Bronson RT, Selfors LM, Mills GB, Brugge JS.

NPJ Breast Cancer. 2017 Sep 22;3:38. doi: 10.1038/s41523-017-0031-9. eCollection 2017.

37.

A comparison of laboratory, clinical, and self-report measures of prospective memory in healthy adults and individuals with brain injury.

Raskin SA, Shum DHK, Ellis J, Pereira A, Mills G.

J Clin Exp Neuropsychol. 2017 Sep 25:1-14. doi: 10.1080/13803395.2017.1371280. [Epub ahead of print]

PMID:
28946819
38.

Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.

Circu M, Cardelli J, Barr M, O'Byrne K, Mills G, El-Osta H.

PLoS One. 2017 Sep 25;12(9):e0184922. doi: 10.1371/journal.pone.0184922. eCollection 2017.

39.

Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer.

Mitra S, Montgomery JE, Kolar MJ, Li G, Jeong KJ, Peng B, Verdine GL, Mills GB, Moellering RE.

Nat Commun. 2017 Sep 22;8(1):660. doi: 10.1038/s41467-017-00888-8.

40.

Current surface ozone concentrations significantly decrease wheat growth, yield and quality.

Pleijel H, Broberg MC, Uddling J, Mills G.

Sci Total Environ. 2018 Feb 1;613-614:687-692. doi: 10.1016/j.scitotenv.2017.09.111. Epub 2017 Sep 26.

PMID:
28938211
41.

Proteomic Features of Colorectal Cancer Identify Tumor Subtypes Independent of Oncogenic Mutations and Independently Predict Relapse-Free Survival.

Clarke CN, Lee MS, Wei W, Manyam G, Jiang ZQ, Lu Y, Morris J, Broom B, Menter D, Vilar-Sanchez E, Raghav K, Eng C, Chang GJ, Simon I, Bernards R, Overman M, Mills GB, Maru D, Kopetz S.

Ann Surg Oncol. 2017 Dec;24(13):4051-4058. doi: 10.1245/s10434-017-6054-5. Epub 2017 Sep 21.

PMID:
28936799
42.

Genomic analysis of exceptional responder to regorafenib in treatment-refractory metastatic rectal cancer: a case report and review of the literature.

Korphaisarn K, Loree JM, Nguyen V, Coulson R, Holla V, Litzenburger BC, Chen K, Mills GB, Maru DM, Meric-Bernstan F, Shaw KRM, Kopetz S.

Oncotarget. 2017 Jun 3;8(34):57882-57888. doi: 10.18632/oncotarget.18357. eCollection 2017 Aug 22.

43.

Derivation and validation of a prognostic model for postoperative risk stratification of critically ill patients with faecal peritonitis.

Tridente A, Bion J, Mills GH, Gordon AC, Clarke GM, Walden A, Hutton P, Holloway PAH, Chiche JD, Stuber F, Garrard C, Hinds C; GenOSept and GAinS Investigators.

Ann Intensive Care. 2017 Sep 12;7(1):96. doi: 10.1186/s13613-017-0314-1.

44.

A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles.

Rebecca VW, Nicastri MC, McLaughlin N, Fennelly C, McAfee Q, Ronghe A, Nofal M, Lim CY, Witze E, Chude CI, Zhang G, Alicea GM, Piao S, Murugan S, Ojha R, Levi SM, Wei Z, Barber-Rotenberg JS, Murphy ME, Mills GB, Lu Y, Rabinowitz J, Marmorstein R, Liu Q, Liu S, Xu X, Herlyn M, Zoncu R, Brady DC, Speicher DW, Winkler JD, Amaravadi RK.

Cancer Discov. 2017 Nov;7(11):1266-1283. doi: 10.1158/2159-8290.CD-17-0741. Epub 2017 Sep 12.

PMID:
28899863
45.

ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma.

Ndoye A, Budina-Kolomets A, Kugel CH 3rd, Webster MR, Kaur A, Behera R, Rebecca VW, Li L, Brafford PA, Liu Q, Gopal YNV, Davies MA, Mills GB, Xu X, Wu H, Herlyn M, Nicastri MC, Winkler JD, Soengas MS, Amaravadi RK, Murphy ME, Weeraratna AT.

Cancer Res. 2017 Nov 1;77(21):5873-5885. doi: 10.1158/0008-5472.CAN-17-0907. Epub 2017 Sep 8.

PMID:
28887323
46.

PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer.

Mjos S, Werner HMJ, Birkeland E, Holst F, Berg A, Halle MK, Tangen IL, Kusonmano K, Mauland KK, Oyan AM, Kalland KH, Lewis AE, Mills GB, Krakstad C, Trovik J, Salvesen HB, Hoivik EA.

Sci Rep. 2017 Aug 31;7(1):10240. doi: 10.1038/s41598-017-10717-z.

47.

Martial arts-based high intensity interval training in the rehabilitation of combat amputees.

Mills GL, Tennent DJ, Aldrete JF, Johnson AE.

US Army Med Dep J. 2017 Jul-Sep;(2-17):53-56. No abstract available.

PMID:
28853120
48.

Martial arts-based high intensity interval training as a component of warfighter rehabilitation and tactical athlete fitness.

Mills GL, Johnson AE.

US Army Med Dep J. 2017 Jul-Sep;(2-17):44-52. No abstract available.

PMID:
28853119
49.

A technique for an arthroscopic proximal biceps tenodesis using a fork anchor.

Amin NH, Volpi A, Simons M, Mills G, Silver S.

J Orthop Surg (Hong Kong). 2017 Sep-Dec;25(3):2309499017727944. doi: 10.1177/2309499017727944.

PMID:
28851262
50.

Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response.

Zervantonakis IK, Iavarone C, Chen HY, Selfors LM, Palakurthi S, Liu JF, Drapkin R, Matulonis U, Leverson JD, Sampath D, Mills GB, Brugge JS.

Nat Commun. 2017 Aug 28;8(1):365. doi: 10.1038/s41467-017-00263-7.

Supplemental Content

Support Center